DexCom stock rises on 2025 outlook
DexCom (NASDAQ:DXCM) shares popped 6% premarket on Monday after the company set its financial forecast for 2025, projecting ...
FierceBiotech12d
Abbott, Dexcom agree to 10-year truce over diabetes sensor patent litigation
Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their ...
DexCom sees FY25 revenue $$4.6B, consensus $4.6B
Dexcom (DXCM) currently anticipates total revenue of $4.6B, representing expected growth of approximately 14% over 2024. This outlook ...
drugdeliverybusiness1d
Dexcom expects sales to grow 14% in 2025
Dexcom (Nasdaq:DXCM) today announced preliminary financial results with projections for significant sales growth in 2025.
NBC New York28d
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
The sensor launched in August and can be used by any adult who doesn't take insulin. The report reflects Dexcom's effort to make Stelo more personalized and engaging for consumers as it works to ...
DexCom Q4 Preliminary Revenue Improves; Pre-Market Stock Up
DexCom, Inc. (DXCM), a maker of continuous glucose monitoring systems for diabetes management, on Monday reported a rise in ...
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Omnipod 5 Automated Insulin ...